Deep Track Capital, LP 13D and 13G filings for Apogee Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 10:18 am Sale |
2024-09-30 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 1,000,000 2.220% |
-1,323,456 (-56.96%) |
Filing |
| 2024-02-14 08:35 am Sale |
2023-12-31 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 2,323,456 6.250% |
-700,000 (-23.15%) |
Filing |
| 2023-07-24 4:05 pm Purchase |
2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE |
Deep Track Capital, LP | 3,023,456 8.870% |
3,023,456 (New Position) |
Filing |